CONTEXT: Over the past few years, reports of emergence and transmission of drug-resistant strains of HIV have increased, especially in western countries. In the context of increased widespread use of zidovudine- and lamivudine-based combinations in India, coupled with the genetic diversity of HIV, it is essential to generate preliminary data on the frequency of zidovudine- and lamivudine-resistant variants of HIV-1 in North India. OBJECTIVES: In the present study, the authors screened for mutations in the pol gene of HIV-1 associated with resistance to zidovudine and lamivudine in HIV-infected treatment-naive patients from North India. DESIGN AND PATIENTS: The mutations were screened at codons 70 and 215 (conferring resistance to zidovudine) and at codon 184 (conferring resistance to lamivudine) by using a nested amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) approach from the proviral DNA of 60 patients. RESULTS: Most of the patients showed a mixture of both wild-type and mutant virus. In all but 1 patient, wild-type virus was observed with respect to each codon. Mutant variants were also observed in many patients, especially at codon 70 (48 patients [80%]) and codon 184 (19 patients [31.67%]). In contrast, the frequency of mutation at codon 215 was found to be very low (1 patient [1.67%]). CONCLUSIONS: In this sample of treatment-naive HIV-1-infected patients in North India, a high proportion of mutant variants harbored mutations in the pol gene at codons- 70 and 184 coexisting with wild-type HIV-1.
CONTEXT: Over the past few years, reports of emergence and transmission of drug-resistant strains of HIV have increased, especially in western countries. In the context of increased widespread use of zidovudine- and lamivudine-based combinations in India, coupled with the genetic diversity of HIV, it is essential to generate preliminary data on the frequency of zidovudine- and lamivudine-resistant variants of HIV-1 in North India. OBJECTIVES: In the present study, the authors screened for mutations in the pol gene of HIV-1 associated with resistance to zidovudine and lamivudine in HIV-infected treatment-naive patients from North India. DESIGN AND PATIENTS: The mutations were screened at codons 70 and 215 (conferring resistance to zidovudine) and at codon 184 (conferring resistance to lamivudine) by using a nested amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) approach from the proviral DNA of 60 patients. RESULTS: Most of the patients showed a mixture of both wild-type and mutant virus. In all but 1 patient, wild-type virus was observed with respect to each codon. Mutant variants were also observed in many patients, especially at codon 70 (48 patients [80%]) and codon 184 (19 patients [31.67%]). In contrast, the frequency of mutation at codon 215 was found to be very low (1 patient [1.67%]). CONCLUSIONS: In this sample of treatment-naive HIV-1-infectedpatients in North India, a high proportion of mutant variants harbored mutations in the pol gene at codons- 70 and 184 coexisting with wild-type HIV-1.
Authors: C A Boucher; E O'Sullivan; J W Mulder; C Ramautarsing; P Kellam; G Darby; J M Lange; J Goudsmit; B A Larder Journal: J Infect Dis Date: 1992-01 Impact factor: 5.226
Authors: I Pellegrin; J Izopet; J Reynes; M Denayrolles; B Montes; J L Pellegrin; P Massip; J Puel; H Fleury; M Segondy Journal: AIDS Date: 1999-09-10 Impact factor: 4.177
Authors: D Boden; A Hurley; L Zhang; Y Cao; Y Guo; E Jones; J Tsay; J Ip; C Farthing; K Limoli; N Parkin; M Markowitz Journal: JAMA Date: 1999 Sep 22-29 Impact factor: 56.272
Authors: M A Wainberg; H Salomon; Z Gu; J S Montaner; T P Cooley; R McCaffrey; J Ruedy; H M Hirst; N Cammack; J Cameron Journal: AIDS Date: 1995-04 Impact factor: 4.177
Authors: M D de Jong; J Veenstra; N I Stilianakis; R Schuurman; J M Lange; R J de Boer; C A Boucher Journal: Proc Natl Acad Sci U S A Date: 1996-05-28 Impact factor: 11.205
Authors: M S Hirsch; B Conway; R T D'Aquila; V A Johnson; F Brun-Vézinet; B Clotet; L M Demeter; S M Hammer; D M Jacobsen; D R Kuritzkes; C Loveday; J W Mellors; S Vella; D D Richman Journal: JAMA Date: 1998-06-24 Impact factor: 56.272
Authors: Mary F Kearney; Jonathan Spindler; Ann Wiegand; Wei Shao; Richard Haubrich; Sharon Riddler; Christina M Lalama; Michael D Hughes; John M Coffin; John W Mellors Journal: PLoS One Date: 2018-01-25 Impact factor: 3.240